TWST ▲ +5.7% - Twist Bioscience Corporation
$TWST Twist Bioscience Joins Lilly TuneLab to Advance Antibody Drug Discovery
Twist Bioscience shares rose 5.7% today following the announcement that the company has joined Eli Lilly's TuneLab collaboration to advance antibody drug discovery. The partnership validates Twist's synthetic biology platform and expands its addressable market in the high-value therapeutic antibody space, likely prompting investor optimism about future revenue opportunities.
16-SEP-2026 08:00 AM ET
Share this post
More filings for $TWST
TWST ▲ +5.7% - Twist Bioscience CorporationSep 16, 2026TWST ▲ +0.3% - Twist Bioscience CorporationSep 9, 2026TWST - Twist Bioscience Corporation - SEC Filing Update (08-SEP-2026) | ThinkSabio - Stocks SimplifiedSep 8, 2026TWST - Twist Bioscience Corporation - SEC Filing Update (08-SEP-2026) | ThinkSabio - Stocks SimplifiedSep 8, 2026TWST - Twist Bioscience Corporation - SEC Filing Update (14-AUG-2026) | ThinkSabio - Stocks SimplifiedAug 14, 2026TWST - Twist Bioscience Corporation - SEC Filing Update (14-AUG-2026) | ThinkSabio - Stocks SimplifiedAug 14, 2026
View full $TWST filing history →💬 Comments
Loading comments…
Leave a comment